Australian Budget Uncertainty Fuels Pharma Anxiety
This article was originally published in PharmAsia News
Executive Summary
The Australian government’s latest federal budget has fuelled anxiety within the pharmaceutical sector with its lack of detail on a much-anticipated review of subsidized medicines that is expected to slash AUD200 million of financial support for popular drugs.